Children's Hospital Medical Center, Cincinnati
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Children's Hospital Medical Center, Cincinnati sits in the top decile of US sponsors by registered trial count (#60 of 15,742 sponsors by registered trial count).
Children's Hospital Medical Center, Cincinnati: 571 sponsored US clinical trials, 106 recruiting.
Children's Hospital Medical Center, Cincinnati sponsors 571 registered US clinical trials on ClinicalTrials.gov, 106 of them currently recruiting, and 372 completed. 38 of these trials are in Phase 3-4 (later-stage) and 140 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 13 trials.
Top-decile sponsor footprint
Children's Hospital Medical Center, Cincinnati ranks in the top decile of sponsors by registered trial count (#60 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
372 of 412 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
571 total, page 1 of 12
The BRIDGE Pain Study
NCT07602595
Sleep and Adolescent Vaccine Immunogenicity Pilot/Observational Study
NCT07636525
Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
NCT07635056
Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)
NCT07628972
18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
NCT07077213
Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency
NCT07433621
Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors
NCT07375290
Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients
NCT07244419
Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation
NCT07217444
Evaluation of the SMART IBD App in Pediatric IBD
NCT07195123
Safety and Efficacy of FETO in CDH Phase III
NCT07187206
Effects of Exercise on Lipids and Endothelial Function in Youth
NCT07409064
Improving ADHD Teen Driving - Virtual Reality
NCT06960980
Survivors Journey+
NCT07321353
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
NCT06175104
Engaging Mental Health Services for Preschoolers at Risk
NCT07054554
Food-based Support for Hospitalized Children and Their Families
NCT06946355
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
NCT06863259
Zemaira Eosinophilic Esophagitis Pilot Study
NCT05485155
Thebaine Urine Testing
NCT07192887
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
NCT06450925
Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
NCT07356050
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
NCT06290401
Autism Doula Program Evaluation
NCT06896942
Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)
NCT07177300
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
NCT06003192
Improving Academic and Social Functioning in Middle-Schoolers With Autism
NCT06705907
I-InTERACT Preterm Parenting
NCT06767293
Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy
NCT06608966
Evaluation of Laparotomy With Trans-Amniotic Suture Placement in TTTS Surgery
NCT06991400
SMART@Home Feasibility Trial
NCT06159127
ADHD PreSMA Response Inhibition Therapy
NCT06325813
Helmsley 3.0: Abbreviated MRE
NCT06533228
STRW-T Intervention for Autistic Adolescents in 11th and 12th Grade
NCT06552286
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
NCT05538208
Comparing Stainless Steel Crowns with Prefabricated Resin Crowns in Primary Molar Teeth
NCT06713330
ES Catheter vs Cryoablation After Pectus Surgery
NCT06682208
Mirdametinib in Histiocytic Disorders
NCT06153173
Chicago Parent Program for Foster and Kinship Caregivers
NCT06170047
Single Arm Romiplostim to Prevent CIT
NCT07048249
Regional Monitoring of CF Lung Disease
NCT06339593
Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia
NCT07325175
Regulating Together in Tuberous Sclerosis Complex
NCT06105736
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
NCT06131801
Speech-in-noise Perception in Autism and Fragile X
NCT06088589
A Novel Obesity Prevention Program for High-Risk Infants in Primary Care
NCT06028113
Responding With Evidence and Access for Childhood Headaches
NCT05889624
Precise Infliximab Exposure and Pharmacodynamic Control
NCT05660746
Safety and Efficacy of PMT Therapy of hPAP
NCT05761899
Violet Light for the Suppression of Myopia
NCT06110520
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 54 |
| Phase 3 | 15 |
| Phase 4 | 23 |
Therapeutic Areas
What is open in the Children's Hospital Medical Center, Cincinnati pipeline
106 recruiting of 571 indexed (19% open); 372 completed (65%).
Phase mix: 38 late (III/IV) vs 140 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Children's Hospital Medical Center, Cincinnati: open-pipeline peers nationwide
Peers matched on 571 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 571 trials (± recruiting share)
- National Institute of Neurological Disorders and Stroke (NINDS) · 567 trials · 8% recruiting
- City of Hope Medical Center · 582 trials · 29% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Amgen · 558 trials · 10% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
- University of Missouri-Columbia · 19% recruiting · 291 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Montefiore Medical Center · 19% recruiting · 345 trials
Related
What to do with this Children's Hospital Medical Center, Cincinnati page
571 registered trials is a research-attention snapshot, not an endorsement of Children's Hospital Medical Center, Cincinnati or any single study.
- 106 of Children's Hospital Medical Center, Cincinnati's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism Spectrum Disorder is the condition Children's Hospital Medical Center, Cincinnati studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Children's Hospital Medical Center, Cincinnati pipeline card: 571 registered trials from official public datasets.Report a data error.